Behrad Derakhshan
Fortune : 960 696 $ au 30/06/2026
Fortune : 960 696 $ au 30/06/2026
Behrad Derakhshan is currently Director at Innoskel SASU and Chief Operating Officer at Edgewise Therapeutics, Inc. Formerly, Dr. Derakhshan was Chief Business Officer at VectivBio AG from 2019 to 2020, Vice President & Head-Business Development at Therachon AG from 2017 to 2019, Director at Alexion Pharmaceuticals, Inc. from 2016 to 2017, and Associate Director at Dymedex Consulting LLC from 2012 to 2015.
Education includes an undergraduate degree from the University of Surrey and a doctorate from Weill Cornell Medicine.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 23 645 ( 0,02 % ) | 960 696 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| EDGEWISE THERAPEUTICS, INC. | Directeur des opérations | 08/01/2025 |
Innoskel SASU
Innoskel SASU BiotechnologyHealth Technology Develops novel therapies | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
VectivBio AG
VectivBio AG BiotechnologyHealth Technology Operates as biotechnology company | Corporate Officer/Principal | 01/09/2020 |
Therachon AG | Corporate Officer/Principal | 01/06/2019 |
| ALEXION PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/04/2017 |
Dymedex Consulting LLC
Dymedex Consulting LLC Miscellaneous Commercial ServicesCommercial Services Provides market development consulting services | Corporate Officer/Principal | 01/01/2015 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 8 |
|---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
University of Surrey
University of Surrey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dymedex Consulting LLC
Dymedex Consulting LLC Miscellaneous Commercial ServicesCommercial Services Provides market development consulting services | Commercial Services |
Edgewise Therapeutics, Inc.
Edgewise Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies for skeletal muscle diseases | Health Technology |
Therachon AG | |
Weill Cornell Medicine
Weill Cornell Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
VectivBio AG
VectivBio AG BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
Innoskel SASU
Innoskel SASU BiotechnologyHealth Technology Develops novel therapies | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national